ABSTRACT
INTRODUCTION
Colorectal cancer (CRC) is a major health problem and is currently ranked third for both cancer incidence and mortality [1] . In spite of the revised treatment patterns, CRC remains a major cause of cancer mortality. At an estimated 1.2 million new cancer cases and 608,700 deaths worldwide each year, people who die from CRC account for 8% of all cancer related deaths [2] . The incidence rate of CRC has been increasing greatly in China in the past few years, which accounts for about 6.5% of total cancers in urban areas and 4.6% in rural areas [3] . CRC is a multifactorial disease, involving the complex interactions between environmental and genetic factors [4] . However, the exact mechanisms which result in the development of colorectal cancer remain unclear. Nowadays, a large
Meta-Analysis
Recently, the associations between vitamin D and colorectal cancer has aroused a great deal of attention, and genetic variation in metabolic pathways for these nutrients may play a role in colorectal carcinogenesis [5] . It's known to us that Vitamin D plays an important role in calcium absorption, cellular proliferation and differentiation, as well as carcinogenesis. Animal studies and case-control studies in humans have provided strong evidence that vitamin D protects against colorectal cancer [6, 7] . Genomic actions of the active metabolite of vitamin D [1, 25(OH) 2 D 3 ] are mediated by the vitamin D receptor (VDR) which maps to a region on chromosome 12 [8, 9] . The active form of vitamin D [1, 25(OH) 2 D 3 ] is bound by the intracellular VDR. This complex bindings and interactions with target-cell nuclei (at VDR elements) produce varieties of biological effects [10] . Recently, the VDR gene polymorphisms including FokI [12, 13, 15, 18, 19, 21-26, 29-32, 35-39, 41-43, 45-47, 49] , BsmI [11-13, 15-18, 20, 23, 26, 27, 29, 30, 32, 33, 36, 37, 40-42, 44, 48, 49] , ApaI [11-13, 15, 16, 18, 23, 27, 28, 30, 36, 41] , TaqI [12-15, 17, 18, 20-24, 27, 28, 31, 36, 38, 41, 49] and Cdx2 [21, 30, 31, 36] have been assessed in genetic associations studies of CRC, but the results from these studies are still inconsistent. Three meta-analyses [3, 50, 51] had been published assessing the associations between VDR polymorphisms and CRC risk in recent years. However, there are some limitations in the three studies, such as relatively small sample size. Moreover, a number of studies that assessed the associations between VDR polymorphisms and CRC risk were published after that period. In order to derive a more comprehensive estimation of the associations between VDR polymorphisms and CRC risk, we conducted a metaanalysis from 39 eligible case-control studies to evaluate the associations. Figure 1 summarizes the selection process of study. According to the strategy, 139 published studies relevant to the VDR genes and the risk of CRC were reviewed including 28 from The Web of Science; 96 from PubMed; five from CBM and 10 from CNKI. 52 articles were selected for full-text review on the basis of their titles and abstracts. Finally, 39 articles met all inclusion criteria and were included in the meta-analysis including 22101 CRC cases and 23696 healthy controls. The 39 articles consisted of five VDR gene polymorphisms including FokI [12, 13, 15, 18, 19, 21-26, 29-32, 34-39, 41-43, 45-47, 49] , BsmI [11-13, 15-18, 20, 23, 26, 27, 29, 30, 32, 33, 36, 37, 40-42, 44, 48, 49] , ApaI [11-13, 15, 16, 18, 23, 27, 28, 30, 36, 41] , TaqI [12-15, 17, 18, 20-24, 27, 28, 31, 36, 38, 41, 49] and Cdx2 [21, 30, 31, 36] . Selected characteristics on the relationships between VDR polymorphisms and CRC were listed in Table 1 .
RESULTS

Data source
Heterogeneity and publication bias
The heterogeneity was assessed for each study using the Q statistic. Significant heterogeneity (P for heterogeneity < 0.10 or I 2 > 50%) between studies were observed in BsmI and ApaI, but no heterogeneity was found in FokI, TaqI and Cdx2 polymorphisms.
Funnel plot and Egger's test were performed to evaluate the publication bias of literatures on CRC, and no statistically significant publication biases were found in all genetic models.
Meta-analysis results
FokI polymorphism and CRC
A total of 29 studies examined the association between CRC and the FokI polymorphism. The result of meta-analysis showed that the FokI polymorphism was on the fringe of statistically significant in the comparison of F allele vs. f allele in fixed model (OR = 1.029, 95%CI = 0.999-1.059, P raw = 0.057, P FDR = 0.057). The homozygous model, the dominant model and the recessive model were no significant associated with CRC risk (Table 2) .
BsmI polymorphism and CRC
There were 23 articles on the relationship between BsmI polymorphism and CRC. We observed significant differences in allele frequencies, the homozygous model and the dominant model between CRC patients and healthy controls (B vs. b: OR = 0.862, 95% CI = 0.761-0.976, P raw = 0.019, P FDR = 0.019; BB vs. bb: OR = 0.786, 95% CI = 0.636-0.972, P raw = 0.026, P FDR = 0.039; BB + Bb vs. bb: OR = 0.824, 95% CI = 0.705-0.964, P raw = 0.015, P FDR = 0.039, respectively). There was little evidence of significant differences that investigated an association between BsmI polymorphism and CRC in the recessive model (Table 2, Figure 2 ).
Other polymorphisms and CRC
Other three polymorphisms including ApaI, TaqI, Cdx2 were not associated with CRC in all genetic models.
Sensitivity analysis
Sensitivity analysis was performed by sequential omission of individual studies. The pooled ORs of the polymorphisms were not altered after omission, indicating that our results were statistically robust. www.impactjournals.com/oncotarget
DISCUSSION
The pathogenesis of CRC remains unknown. Geneenvironment interactions, gene-gene interactions and life-style have an important impact on the development of CRC. There is consistent epidemiologic evidence that increased vitamin D intake is associated with reduced risk of colorectal. VDR mediate the biological activity of vitamin D and plays a crucial role in the etiology and development of cancer. A number of genetic associations studies were carried out to investigate the association of VDR polymorphisms with CRC risk, but the results are conflictive and the effect of VDR polymorphisms on CRC remains unclear. Therefore, in order to overcome the limitations of individual studies, we performed meta-analysis to evaluate the associations As in any study, some limitations of this study should be considered. First, only published studies in English and Chinese were included in this meta-analysis, so publication bias may have occurred. Second, significant heterogeneity was observed in overall comparisons. Although no publication bias was observed, different background and variant adjusted factors of controls were possible major source of heterogeneity. Third, although environment and diet may partially contribute to CRC, gene-gene and gene-environment interactions could not be investigated. Fourth, meta-analysis was still an observational study that subjected to the methodological deficiencies of the included studies.
In conclusion, this meta-analysis suggests that BsmI was associated with CRC risk and FokI might be risk factors for CRC. However, these associations with CRC need further studied. 
MATERIALS AND METHODS
Literature search strategy
All genetic association studies that assessed the associations of the FokI, BsmI, ApaI, TaqI and Cdx2 polymorphisms in the VDR genes with CRC susceptibility were included/enrolled in the meta-analysis. The studies were identified by extended computer based search of The PubMed, Web of Science, the Chinese Biomedical Database (CBM) and Chinese National Knowledge Infrastructure (CNKI) and Wanfang (Chinese) databases (published until April 2017). The keywords "Colorectal cancer" or "CRC" or "Colorectal carcinoma" or "Colorectal tumor", "polymorphism" or "variant" or "genes" or "genotypes" or "genotyping", "vitamin D receptor" or "VDR" were used. All references cited in the publications were also reviewed to identify other relevant publications. Finally, only published studies with full text were included.
Inclusion and exclusion criteria
Regarding CRC susceptibility and VDR gene polymorphisms, studies which satisfy all the following criteria were identified: (1) articles investigate the associations of the FokI, BsmI, ApaI, TaqI and Cdx2 polymorphisms in the VDR genes with the development of CRC; (2) a case-control study; (3) articles reported the number of individual genotypes and/or alleles for VDR polymorphisms in cases and controls; (4) the paper should clearly describe CRC diagnoses; (5) the control' ethnic background and geographic area were the same with case'; (6) the language of articles was restricted to English or Chinese; (7) full text was available. Exclusion criteria: (1) the study was conducted on animals; (2) abstracts, case reports, editorials and review articles were excluded; (3) studies that did not met the inclusion criteria; (4) study with no detailed data.
Data extraction
According to the selection criteria, data from relevant studies were carefully and independently extracted by two authors (Zhipeng Pan and Mengya Chen). Disagreement was resolved by discussion and consultation with the third researcher (Xingxing Hu). The following data were extracted if available: first author, year of publication, country, ethnicity of study population, the genotyping method, sample size, number of each genotype in cases and controls.
Statistical analysis
The strength of the associations between the VDR polymorphisms and CRC susceptibility were evaluated by Odds ratios (ORs) with 95% confidence intervals (95% CIs) under the appropriate genetic model. The pooled ORs were calculated for the allele contrasts, homozygous model, recessive genetic model and dominant genetic model. P value < 0.05 was considered to be statistically significant comparing CRC cases with controls. Considering the possibility of heterogeneity in the studies, heterogeneity assumption was measured by the chi-square based Q test (P < 0.1 indicates heterogeneity) [52] . In addition, the presence of heterogeneity between studies was tested by the I 2 . I 2 values of 25, 50, and 75% are defined as low, moderate, and high estimates, respectively. The pooled effect was calculated by a fixed effect model when there is no heterogeneity (I 2 < 50% or P > 0.1), otherwise, a random effects model was used. HWE was assessed by the Chi-square test in the control group of each study in all the included studies (P < 0.05 was considered significant). The funnel plot and Egger's regression test were used to search for publication bias, and an asymmetric Funnel plot or P < 0.05 in Egger weighted regression suggested possible publication bias. In consideration of multiple comparisons, Benjamini-Hochberg (BH) method was applied to control the false discovery rate (FDR). All the statistical manipulations were performed using the STATA statistical software 11.0 (StataCorp, College Station, TX, USA) and Review Manager Software 5.1 (Cochrane Collaboration, Oxford, UK). All P values tested were two-tailed. Homozygous model.
